Different versions of APOE protein have varying effects on microglia in Alzheimer’s disease

A new study, published today in Nature Communications, offers clues into how APOE isoforms differentially affect human microglia function in Alzheimer’s disease. The study, led by Dr. Sarah Marzi and Dr. Kitty Murphy at the UK Dementia Research Institute at King’s College London and the Department of Basic and Clinical Neuroscience, underscores the need for new targeted interventions based on APOE genotypes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup